Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats
Food & Function · 2023 · 14 (8) · 3588-3599
DOI: 10.1039/d2fo03030f ↗Kurz gefasst
Fachartikel in der Zeitschrift Food & Function, 2023. Verfasst von Xiaoyu Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, P. R. China. zhouhuifen2320@126.com. Hauptthemen laut MEDLINE: Brain Ischemia, Drugs, Chinese Herbal, Brain Injuries. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Based on transcriptomic, proteomic, and metabolomic analyses, we developed an strategy to explore the key targets and mechanisms of Astragaloside IV treatment for cerebral ischemia in rats to obtain a compound–reaction–enzyme–gene network.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, P. R. China. zhouhuifen2320@126.com.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wei, X., He, Y., Wan, H., Yin, J., Lin, B., Ding, Z., Yang, J., & Zhou, H. (2023). Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats. Food & Function, 14(8), 3588-3599. https://doi.org/10.1039/d2fo03030f
Vancouver
Wei X, He Y, Wan H, Yin J, Lin B, Ding Z, et al. Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats. Food & Function. 2023;14(8):3588-3599. doi:10.1039/d2fo03030f
BibTeX
@article{Wei2023,
author = {Wei, Xiaoyu and He, Yu and Wan, Haitong and Yin, Junjun and Lin, Bingying and Ding, Zhishan and Yang, Jiehong and Zhou, Huifen},
title = {Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats},
journal = {Food & Function},
year = {2023},
volume = {14},
number = {8},
pages = {3588--3599},
doi = {10.1039/d2fo03030f}
}
EUVIMED